InvestorsHub Logo
Followers 51
Posts 9008
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Wednesday, 05/18/2022 8:07:57 AM

Wednesday, May 18, 2022 8:07:57 AM

Post# of 13336
IAVI AND MODERNA LAUNCH FIRST-IN-AFRICA CLINICAL TRIAL OF MRNA HIV VACCINE DEVELOPMENT PROGRAM

NEW YORK, NY and CAMBRIDGE, MA / ACCESSWIRE / May 18, 2022 / The nonprofit scientific research organization IAVI and Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participant screenings are soon to start for a Phase I clinical trial of an mRNA HIV vaccine antigen (mRNA-1644) at the Center for Family Health Research (CFHR) in Kigali, Rwanda, and The Aurum Institute in Tembisa, South Africa.


https://investors.modernatx.com/news/news-details/2022/IAVI-and-Moderna-Launch-First-in-Africa-Clinical-Trial-of-mRNA-HIV-Vaccine-Development-Program/default.aspx
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News